[S-20] Symposium 20 Cutting-edge advances in NMOSD and MOG-related disorders

[S-20-5] Treatment strategy for MOGAD

^○Sung Min Kim (Department of Neurology, Seoul National University Hospital, Korea)

Dr. Sung-Min Kim is an associate professor at the Department of Neurology of Seoul National University Hospital in Seoul, South Korea. He is also a director of the international committees of the Korean Society of Neuroimmunology and also a scientific committee of the Korean Society of Intraoperative Neurophysiological Monitoring.
Dr. Kim completed his medical degree at Seoul National University in 2001. He completed his residency in the Department of Neurology of the same institution in 2006. In 2007, he pursued a master’s degree, followed by a fellowship in neuromuscular disorders in 2008. In 2010 he undertook a role as a visiting physician at the University of Chicago Medical Center, Chicago, IL, USA. Dr. Kim became an assistant professor at Seoul National University Hospital in 2011, was awarded his PhD in 2014, and rose to the rank of associate professor in 2017.
Dr. Kim’s primary research interests include multiple sclerosis, myelitis, optic neuritis, and optic neuritis. He has published extensively on many of these research subjects and has conducted several phase III clinical trials of agents against neuromyelitis optica, amyotrophic lateral sclerosis, and multiple sclerosis.